Myelodysplastic syndromes: A practical approach to diagnosis and treatment

被引:26
作者
Barzi, Afsanen [2 ]
Sekeres, Mikkael A. [1 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44195 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
COLONY-STIMULATING FACTOR; UNITED-STATES; EPIDEMIOLOGY; SURVIVAL; CLASSIFICATION; ERYTHROPOIETIN; AZACITIDINE; PROGNOSIS; LEUKEMIA; EFFICACY;
D O I
10.3949/ccjm.77a.09069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The myelodysplastic syndromes (MDS) are clonal bone marrow disorders that lead to underproduction of normal blood cells. The consequent cytopenias result in infections and bleeding complications. MDS transform to acute myeloid leukemia in one-third of patients. The number of diagnoses has exploded in the past decade as a result of increased recognition and understanding of the disease and the aging of the population. New therapies can extend life. MDS are now considered the most common form of leukemia, and in some cases deserve immediate intervention. This review describes common presentations of MDS, optimal diagnostic approaches, and therapies for lower- and higher-risk disease.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 35 条
[1]   A comparative review of classification systems in myelodysplastic syndromes (MDS) [J].
Bennett, JM .
SEMINARS IN ONCOLOGY, 2005, 32 (04) :S3-S10
[2]   Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: A case-control study [J].
Bjork, Jonas ;
Johansson, Bertil ;
Broberg, Karin ;
Albin, Maria .
LEUKEMIA RESEARCH, 2009, 33 (06) :788-791
[3]   Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes [J].
Bowen, D ;
Culligan, D ;
Jowitt, S ;
Kelsey, S ;
Mufti, G ;
Oscier, D ;
Parker, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) :187-200
[4]   Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [J].
Cheson, Bruce D. ;
Greenberg, Peter L. ;
Bennett, John M. ;
Lowenberg, Bob ;
Wijermans, Pierre W. ;
Nimer, Stephen D. ;
Pinto, Antonio ;
Beran, Miloslav ;
de Witte, Theo M. ;
Stone, Richard M. ;
Mittelman, Moshe ;
Sanz, Guillermo F. ;
Gore, Steven D. ;
Schiffer, Charles A. ;
Kantarjian, Hagop .
BLOOD, 2006, 108 (02) :419-425
[5]   A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes:: delayed transplantation for low-risk myelodysplasia is associated with improved outcome [J].
Cutler, CS ;
Lee, SJ ;
Greenberg, P ;
Deeg, HJ ;
Pérez, WS ;
Anasetti, C ;
Bolwell, BJ ;
Cairo, MS ;
Gale, RP ;
Klein, JP ;
Lazarus, HM ;
Liesveld, JL ;
McCarthy, PL ;
Milone, GA ;
Rizzo, JD ;
Schultz, KR ;
Trigg, ME ;
Keating, A ;
Weisdorf, DJ ;
Antin, JH ;
Horowitz, MM .
BLOOD, 2004, 104 (02) :579-585
[6]   Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].
Fenaux, Pierre ;
Mufti, Ghulam J. ;
Hellstrom-Lindberg, Eva ;
Santini, Valeria ;
Finelli, Carlo ;
Giagounidis, Aristoteles ;
Schoch, Robert ;
Gattermann, Norbert ;
Sanz, Guillermo ;
List, Alan ;
Gore, Steven D. ;
Seymour, John F. ;
Bennett, John M. ;
Byrd, John ;
Backstrom, Jay ;
Zimmerman, Linda ;
McKenzie, David ;
Beach, C. L. ;
Silverman, Lewis R. .
LANCET ONCOLOGY, 2009, 10 (03) :223-232
[7]   Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes [J].
Germing, Ulrich ;
Aul, Carlo ;
Niemeyer, Charlotte M. ;
Haas, Rainer ;
Bennett, John M. .
ANNALS OF HEMATOLOGY, 2008, 87 (09) :691-699
[8]  
Giralt Sergio, 2005, Curr Hematol Rep, V4, P200
[9]   Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes [J].
Golshayan, Ali-Reza ;
Jin, Tao ;
Maciejewski, Jaroslaw ;
Fu, Alex Z. ;
Bershadsky, Boris ;
Kattan, Michael W. ;
Kalaycio, Matt E. ;
Sekeres, Mikkael A. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (02) :125-132
[10]   International scoring system for evaluating prognosis in myelodysplastic syndromes [J].
Greenberg, P ;
Cox, C ;
LeBeau, MM ;
Fenaux, P ;
Morel, P ;
Sanz, G ;
Sanz, M ;
Vallespi, T ;
Hamblin, T ;
Oscier, D ;
Ohyashiki, K ;
Toyama, K ;
Aul, C ;
Mufti, G ;
Bennett, J .
BLOOD, 1997, 89 (06) :2079-2088